01.04.2016 | Image of the Month
68Ga-PSMA PET/CT imaging in primary hepatocellular carcinoma
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 4/2016
Einloggen, um Zugang zu erhaltenExcerpt
68Ga-labelled prostate-specific membrane antigen (PSMA) is emerging as the tool with the most potential for imaging recurrent prostate cancer [1]. There have been a few reports of significant accumulation of the tracer in metastatic clear cell renal carcinoma [2] and metastatic breast cancer [3]. The expression of PSMA in tumour-associated vasculature of breast cancer and primary gliomas has been reported [4]. Similar to prostate cancer, 18F-FDG PET/CT is also not the best imaging option in primary hepatocellular carcinoma (HCC). The potential of 68Ga-PSMA for imaging primary HCC is not yet documented. …Anzeige